Non Small Cell Lung Cancer: Page 2

Agilent announces FDA approval for non-small cell lung cancer CDx
Resolution ctDx First is a liquid biopsy next-generation sequencing (NGS) assay; it has also been approved by the FDA for tumor profiling of the epidermal growth factor receptor (EGFR) gene in patients with NSCLC.
December 13, 2022
Lung Cancer Hotspot Social
Cofactor Genomics kicks off study of multidimensional immune biomarker assay for NSCLC
The firm's OncoPrism diagnostic platform generates multidimensional immune biomarkers using predictive immune modeling.
December 15, 2022
Lung Cancer Social
Qiagen obtains FDA approval for NSCLC companion diagnostic assay
Therascreen KRAS is a tissue-based polymerase chain reaction (PCR) assay designed to identify NSCLC patients likely to respond to treatment with Mirati Therapeutics’ Krazati (adagrasib).
December 13, 2022
Cancer Lung 3 D Black Social
OncoHost preparing launch of proteomics diagnostics platform for cancer, immunotherapy
The appointments come ahead of the company's launch of its AI-powered diagnostic platform called PROphet.
October 3, 2022
Lung Cancer2 Social
Foundation to present on genomic profiling at ESMO 2022
At the congress, which is being held in Paris September 9-13, Foundation Medicine will highlight the following:
September 6, 2022
2020 01 16 22 39 3973 Dna Sequencing Genome 400
Thermo Fisher launches NGS test, software for clinical labs
Using targeted NGS technology, the Oncomine Dx Express Test delivers clinically relevant tumor mutation profiling in 24 hours to aid healthcare professionals in therapy management of cancer patients in accordance with professional guidelines, Thermo Fisher said.
August 29, 2022
2022 03 01 17 44 8262 Sequencing Virus 400
Thermo Fisher, Guardant Health get approval for NSCLC CDx
Enhertu is an HER2-directed antibody drug conjugate being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca.
August 11, 2022
2022 08 08 21 26 6857 Lung Cancer2 400
Foundation Medicine highlights lung cancer study results
The findings are from the Prospective Clinicogenomic (PCG) study and were published August 5 in the Journal of Thoracic Oncology Clinical and Research Reports.
August 7, 2022
2021 11 10 18 26 8156 Science Genome Sequence Dna Map 400
Biodesix touts VeriStrat test results
The blood-based test was predictive of progression-free survival and overall survival in patients with non-small cell lung cancer with low or negative PD-L1 treated with immune checkpoint inhibitors, the firm said.
July 19, 2022
2019 09 09 20 46 2283 Lung Cancer 400
BillionToOne launches liquid biopsy products for research
The products are available for research use in select academic cancer centers.
July 7, 2022
2022 05 27 20 42 7840 Doctor Lab Test Bipoc 400
Biocartis, AstraZeneca to develop CDx for EGFR TKI treatment
The firms aim to obtain applicable premarket notification or approval from the U.S. Food and Drug Administration (FDA) for a CDx test on Biocartis' fully automated molecular Idylla platform.
June 21, 2022
2019 09 09 20 46 2283 Lung Cancer 400
Foundation Medicine gets FDA nod for NSCLC CDx
Rozlytrek is a targeted therapy for the treatment of non-small cell lung cancer (NSCLC) developed by Roche's Genentech.
June 8, 2022
2019 10 09 17 32 0093 Dna Cancer Cell 400
Previous Page
Page 2 of 5
Next Page